DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P.
Human anti-tumor necrosis factor monoclonal antibody (adalimumab)
in Crohn’s disease: the CLASSIC-I trial.
Gastroenterology 2006; 130: 323-333
We do not assume any responsibility for the contents of the web pages of other providers.